Last update 01 Nov 2024
JW Therapeutics (Suzhou) Co., Ltd.
Last update 01 Nov 2024
Overview
Tags
Neoplasms
Immune System Diseases
Hemic and Lymphatic Diseases
Autologous CAR-T
TCR therapy
Biological products
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
瑞基奥仑赛注射液（CD19靶向嵌合抗原受体T细胞）治疗复发/难治性大B细胞淋巴瘤成年患者的开放、单臂研究
[Translation] An open-label, single-arm study of Regimen (CD19-targeted chimeric antigen receptor T cells) in adult patients with relapsed/refractory large B-cell lymphoma
瑞基奥仑赛注射液（CD19靶向嵌合抗原受体T细胞）治疗复发难治性大B细胞淋巴瘤的开放、单臂、多中心研究
[Translation] An open, single-arm, multicenter study of Regimen Injection (CD19-targeted chimeric antigen receptor T cells) in the treatment of relapsed and refractory large B-cell lymphoma
瑞基奥仑赛注射液治疗复发或难治性大B细胞淋巴瘤真实世界研究
[Translation] A real-world study of Requiorencel injection in the treatment of relapsed or refractory large B-cell lymphoma
100 Clinical Results associated with JW Therapeutics (Suzhou) Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with JW Therapeutics (Suzhou) Co., Ltd.
Login to view more data
100 Translational Medicine associated with JW Therapeutics (Suzhou) Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 22 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
4
1
Phase 1 Clinical
NDA/BLA
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free